QNZ

Manufacturer	TargetMol
Category	Metabolism Diabetes Glucose Homeostasis Reagents & Chemicals Molecules
Type	Molecules
Specific against	other
Amount	25mg
Item no.	TMO-T6204-25mg
CASRN	545380-34-5
eClass 6.1	32169090
eClass 9.0	32169090
Available
Short Description	QNZ (EVP4593) is an effective inhibitor of NF-κB activation and TNF-α production. The IC50 of QNZ for NF-κB and TNF-α is11 nM and 7 nM, respectively.
Shipping	cool pack
Storage	-20°
Target names or alias	CAY10470 , EVP4593
Molecular Weight	356, 42
Pathway	Apoptosis\|\|\|NF-Κb
Target	TNF\|\|\|NF-κB

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 25mg

available

Delivery expected until 5/23/2024